In another study, nanobody-albumin nanoparticles (NANAPs) were used for the delivery of 17864-Lx-a, a platinum-bound sunitinib analogue multikinase inhibitor, to EGFR overexpressing tumour cells. This evidence concerns the gene EGFR and neoplasm.